- Published:
Chemical Restraint-Reversal with Medetomidine and Atipamezole in Veterinary Small Animal Practice: A Survey on the Opinions of the Dog Owners and Veterinarians
Kemisk inaktivering-upphävning med medetomidin och atipamezol i Veterinär små djurspraktik: Ett sammandrag av djurägares och praktiserande veterinärers åsikter.
Acta Veterinaria Scandinavica volume 32, pages 387–393 (1991)
Abstract
The opinions of animal owners and practising veterinarians concerning a new restraint-reversal medication (medetomidine-atipamezole) for dogs were obtained by two questionnaires in connection with a clinical study. Four alternative answers to each statement question scored as “completely agree”, “somewhat agree”, “somewhat disagree” and “completely disagree”. The questionnaires were completed by 21 veterinarians and 245 dog owners.
The overall response to the treatment was clearly positive. Both groups had a favourable attitude towards drug use with mean combined scores (from 1 to 4; 4 = most favourable) of 48.1 (max 56) for the dog owners and 39.2 (max 52) for the veterinarians. Only a little information was gained about the background of negative sentiments. Some pet owners (19%) opposed to medication on a priori grounds, some (26 %) reacted strongly to the dizziness of their animals and some owners (21 %) complained because of general anxiety before, during and after their pets were treated.
Sammanfattning
Djurägares och praktiserande veterinärers åsikt angående en ny restraint-recovery-medikation (medetomidin-atipamezol) för hundar framgick ur frågeformulär som fylldes i samband med en klinisk prövning. De fyra svarsalternativen var “överensstämmer helt”, “överensstämmer nästan helt”, “oöverensstämmer nästan helt” och oöverensstämmer helt”. Tjugoen veterinärer och 245 hundägare fyllde i formulären.
Den allmänna responsen gentemot läkemedelsbehandlingen var klart positiv: både hundägarna och veterinärerna visade en gynnsam attityd med medeltalpoäng (från 1 till 4; 4 = gynnsammast) för en enskild deltagare på 48,1 (max 56) och 39,2 (max 54). Mycket litet information framkom angående bakgrunden för negativ inställning. Några djurägare (19%) godkände inte medikationen p.g.a. tidigare erfarenhet, några (26 %) reagerade starkt för djurens yrsel och några ägare (21 %) klagade över ångest före, under och efter djurets behandling.
References
Anonymous: What your clients think of you! Mod. vet. Pract. 1982, 63, 96–101.
Beaver BV: Knowing our clients and patients. Vet. med./Small anim. Clin. 1981, 76, 1551–1554.
Blackshaw JK: Human – animal inter-relationships. Review series 8: Veterinarian-client relationships. Austral, vet. Pract. 1986, 16, 24–27.
Booth NH: Neuroleptanalgesics, narcotic analgesics, and analgesic antagonists. In: Booth NH, McDonald LE (eds.): Veterinary Pharmacology and Therapeutics. Ames, Iowa State University Press 1988, 323–325.
Hatch RC, Kitzman JV, Zahner JM, Clark JD: Antagonism of xylazine sedation with yohimbine, 4-aminopyridine, and doxapram in dogs. Amer. J. vet. Res. 1985, 46, 371–375.
McCurnin DM: Veterinary Practice Management. J. B. Lippincott Company, Philadelphia PA, 1988, p. ix.
Vähä- Vahe T: Clinical evaluation of medetomidine, a novel sedative and analgesic drug for dogs and cats. Acta vet. scand. 1989, 30, 267–273.
Vähä- Vahe T: The clinical effectiveness of atipamezole as a medetomidine antagonist in dogs. J. vet. Pharmacol. Ther. 1990, 13, 198–205.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Vähä- Vahe, T., Niemi, P. & Tuominen, J. Chemical Restraint-Reversal with Medetomidine and Atipamezole in Veterinary Small Animal Practice: A Survey on the Opinions of the Dog Owners and Veterinarians. Acta Vet Scand 32, 387–393 (1991). https://doi.org/10.1186/BF03546969
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1186/BF03546969